THE IMPACT OF BIG DATA ON PERSONALIZED MEDICINE IN PHARMA
Keywords:
Big Data, Personalized Medicine, Pharmaceutical Industry, Genomics, Healthcare AnalyticsAbstract
This article explores the transformative impact of Big Data on personalized medicine in the pharmaceutical industry. It traces the evolution from traditional "one-size-fits-all" approaches to tailored treatments, highlighting the role of advanced technologies in analyzing vast amounts of patient data. Integrating genomic information, electronic health records, and real-time health monitoring devices has enabled more precise diagnoses and targeted therapies. The article discusses applications in key therapeutic areas, such as oncology and chronic diseases, where Big Data has significantly improved patient outcomes. While acknowledging the immense potential, the article addresses challenges including data privacy, integration complexities, and ethical considerations. Looking to the future, it examines how advancements in AI, machine learning, and collaborative efforts between various stakeholders are poised to revolutionize healthcare delivery, promising a new era of efficient, effective, and highly personalized medical care.
References
J. Schwaederle et al., "Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials," Journal of Clinical Oncology, vol. 33, no. 32, pp. 3817-3825, 2015. [Online]. Available: https://ascopubs.org/doi/10.1200/JCO.2015.61.5997
R. L. Siegel, K. D. Miller, and A. Jemal, "Cancer statistics, 2020," CA: A Cancer Journal for Clinicians, vol. 70, no. 1, pp. 7-30, 2020. [Online]. Available: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21590
J. A. DiMasi, H. G. Grabowski, and R. W. Hansen, "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, vol. 47, pp. 20-33, 2016. [Online]. Available: https://www.sciencedirect.com/science/article/abs/pii/S0167629616000291
E. Abrahams and M. Silver, "The case for personalized medicine," Journal of Diabetes Science and Technology, vol. 3, no. 4, pp. 680-684, 2009. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769975/
P. B. Jensen, L. J. Jensen, and S. Brunak, "Mining electronic health records: towards better research applications and
clinical care," Nature Reviews Genetics, vol. 13, no. 6, pp. 395-405, 2012. [Online]. Available: https://www.nature.com/articles/nrg3208
W. Raghupathi and V. Raghupathi, "Big data analytics in healthcare: promise and potential," Health Information Science and Systems, vol. 2, no. 1, p. 3, 2014. [Online]. Available: https://link.springer.com/article/10.1186/2047-2501-2-3
J. C. Zao et al., "Big data application in biomedical research and health care: A literature review," Biomedical Informatics Insights, vol. 8, pp. 1-10, 2016. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720168/
E. Choi, M. T. Bahadori, A. Schuetz, W. F. Stewart, and J. Sun, "Doctor AI: Predicting Clinical Events via Recurrent Neural Networks," JMLR Workshop and Conference Proceedings, vol. 56, pp. 301-318, 2016. [Online]. Available: http://proceedings.mlr.press/v56/Choi16.html
L. J. Kish and E. J. Topol, "Unpatients—why patients should own their medical data," Nature Biotechnology, vol. 33, no. 9, pp. 921-924, 2015. [Online]. Available: https://www.nature.com/articles/nbt.3340
I. S. Kohane, "Ten things we have to do to achieve precision medicine," Science, vol. 349, no. 6243, pp. 37-38, 2015. [Online]. Available: https://science.sciencemag.org/content/349/6243/37
E. J. Topol, "High-performance medicine: the convergence of human and artificial intelligence," Nature Medicine, vol. 25, no. 1, pp. 44-56, 2019. [Online]. Available: https://www.nature.com/articles/s41591-018-0300-7
K. T. Pickard et al., "Precision Medicine: From Science to Value," Health Affairs, vol. 37, no. 5, pp. 694-701, 2018. [Online]. Available: https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2017.1624
